AbCellera Biologics Inc. (ABCL) vs Option Care Health, Inc. (OPCH)

A side-by-side comparison of AbCellera Biologics Inc. and Option Care Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ABCL vs OPCH

growth of $100 · dividends reinvested · last 6y
ABCL -76.6% (-21.5%/yr)OPCH +46.2% (+6.5%/yr)OPCH compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$23$146
ABCL OPCH

ABCL vs OPCH: by the numbers

  • •OPCH is the larger company ($4.64B vs $4.02B market cap).
  • •OPCH is profitable (3.68% net margin) while ABCL runs a net loss (-248.83%).
  • •OPCH grew revenue faster over the past five years (12.17% vs -31.78% CAGR).

Metrics side by side

Valuation

MetricABCLOPCH
P/E ratioN/A23.31
Forward P/EN/A16.49
P/S ratio60.680.82
P/B ratio4.483.69
EV / EBITDAN/A13.96

Profitability

MetricABCLOPCH
Gross margin61.64%18.17%
Operating margin-288.98%5.94%
Net margin-248.83%3.68%
ROE-18.38%16.63%
ROIC-17.95%9.68%

Growth (annualized)

MetricABCLOPCH
Revenue CAGR (5Y)-31.78%12.17%
Total return CAGR (5Y)-3.57%-1.37%

Frequently asked

Which has grown faster, ABCL or OPCH?
Over the past five years, OPCH grew revenue faster — ABCL at a -31.78% CAGR versus OPCH at 12.17%.
Is ABCL or OPCH more profitable?
OPCH runs the higher net margin — ABCL at -248.83% versus OPCH at 3.68%.
How have ABCL and OPCH total returns compared?
Over the past 5 years, ABCL delivered -3.57% and OPCH delivered -1.37% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.